BRPI0910168A2 - "vacina anti-helmíntica multivalente e método de vacinar um indivíduo em necessidade da mesma contra infecção por ancilóstomo e esquistossomose" - Google Patents

"vacina anti-helmíntica multivalente e método de vacinar um indivíduo em necessidade da mesma contra infecção por ancilóstomo e esquistossomose"

Info

Publication number
BRPI0910168A2
BRPI0910168A2 BRPI0910168A BRPI0910168A BRPI0910168A2 BR PI0910168 A2 BRPI0910168 A2 BR PI0910168A2 BR PI0910168 A BRPI0910168 A BR PI0910168A BR PI0910168 A BRPI0910168 A BR PI0910168A BR PI0910168 A2 BRPI0910168 A2 BR PI0910168A2
Authority
BR
Brazil
Prior art keywords
schistosomiasis
vaccinating
multivalent
individual
need
Prior art date
Application number
BRPI0910168A
Other languages
English (en)
Inventor
Loukas Alexander
Shah Brown Ami
Zhan Bin
Diemert David
Goud Gaddam
Bethony Jeffrey
Elena Bottazzo Maria
Pearson Mark
Giacomantonio Peter
Hotez Peter
Original Assignee
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ George Washington filed Critical Univ George Washington
Publication of BRPI0910168A2 publication Critical patent/BRPI0910168A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0910168A 2008-07-01 2009-06-30 "vacina anti-helmíntica multivalente e método de vacinar um indivíduo em necessidade da mesma contra infecção por ancilóstomo e esquistossomose" BRPI0910168A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7725608P 2008-07-01 2008-07-01
PCT/US2009/049220 WO2010002867A2 (en) 2008-07-01 2009-06-30 Multivalent antihelminthic vaccine

Publications (1)

Publication Number Publication Date
BRPI0910168A2 true BRPI0910168A2 (pt) 2019-09-24

Family

ID=41466561

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910168A BRPI0910168A2 (pt) 2008-07-01 2009-06-30 "vacina anti-helmíntica multivalente e método de vacinar um indivíduo em necessidade da mesma contra infecção por ancilóstomo e esquistossomose"

Country Status (4)

Country Link
US (1) US8444994B2 (pt)
AU (1) AU2009267070A1 (pt)
BR (1) BRPI0910168A2 (pt)
WO (1) WO2010002867A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
EP4237853A1 (en) * 2020-10-27 2023-09-06 Merck Patent GmbH Proteins for the detection of schistosoma infection
CN115043922B (zh) * 2022-03-30 2023-09-15 中国医学科学院病原生物学研究所 日本血吸虫抗原蛋白rSjScP57及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US20030092145A1 (en) * 2000-08-24 2003-05-15 Vic Jira Viral vaccine composition, process, and methods of use
US7303752B2 (en) * 2001-10-17 2007-12-04 The George Washington University Hookworm vaccine
US20110158998A1 (en) * 2005-08-03 2011-06-30 The Council Of The Queensland Institute Of Medical Research Helminth antigen and immunotherapy

Also Published As

Publication number Publication date
WO2010002867A3 (en) 2010-05-20
US8444994B2 (en) 2013-05-21
US20110200640A1 (en) 2011-08-18
WO2010002867A8 (en) 2010-04-01
WO2010002867A2 (en) 2010-01-07
AU2009267070A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
BRPI0922205A2 (pt) "aparelho de implantação de fibra ótica em unidade de múltiplas residências e métodos para usar o mesmo".
BRPI0822920A2 (pt) Implante médico e método de implantação
EP2515981A4 (en) PATIENT INTERFACE AND HEAD PROTECTION
BRPI0813989A2 (pt) Dispositivo e método de retração de tecido gengival
BRPI0916150A2 (pt) ''método de infusão intradérmica e dispositivo de aplicação de medicamento''
PL2087913T3 (pl) System i sposób sterylizacji wszczepialnego urządzenia medycznego
EP2244720A4 (en) POLYPEPTIDE VACCINE AND VACCINE STRATEGY AGAINST MYCOBACTERIUM
BR112012004148A2 (pt) "dispositivo médico para colocação em um lúmen e método de fabricação do mesmo"
BRPI0914387A2 (pt) sistema de tratamento abdominal, método de tratamento de uma cavidade abdominal aberta, e, método de fabricação de um sistema para tratamento de uma cavidade abdominal de um paciente
BRPI0907109A2 (pt) lenço dental e método
EP1991262A4 (en) MYCOPLASMA HYOPNEUMONIAE VACCINE
PL2516002T3 (pl) Preparat do leczenia i/lub zapobiegania stanom chorobowym spowodowanym przez mikroorganizmy z zastosowaniem doustnego urządzenia świetlnego
BRPI0916269A2 (pt) dispositivo de modificação de tecido e seu método de uso
BR112012021522A2 (pt) bráquete ortodôntico para um sistema ortodôntico, sistema de bráquete ortodôntico, kit ortodôntico, processo para fabricar um bráquete ortodôntico e método para tratar a mordida de um paciente humano
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
BRPI0717732A2 (pt) Guia cirúrgica para implante dental e métodos para o mesmo
EP2320185A4 (en) DRY CLEANING DEVICE AND DRY CLEANING PROCESS
BR112012009265A2 (pt) dispositivo de interface de paciente e metodo de ajuste de um dispositivo de interface de paciente
BR112012005015A2 (pt) dispositivos de tratamento médico de fibra óptica de emissão assimétrica de radiação fora do eixo e métodos de tratamento para escavação ou ablação de cavidade em tecido humano ou animal
BR112012009261A2 (pt) ''dispositivo de interface do paciente e método de ajuste do dispositivo de interface do paciente''
EP2400916A4 (en) DENTAL AND MEDICAL TREATMENTS AND METHOD
BRPI0911656A2 (pt) formulações de nanopartículas e usos das mesmas
BRPI0914192A2 (pt) distribuição transdérmica de fármaco usando um osmólito e agente vasoativo
BRPI0920026A2 (pt) método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.